A New Dawn for Early Breast Cancer: Enhertu's Groundbreaking Impact Revealed at ESMO 2025

FDA Approves Tezspire Self-Administration, Revolutionizing Severe Asthma Care for Amgen and AstraZeneca

AstraZeneca's Landmark Deal: Lowering Drug Prices for Medicaid Under Trump Administration Agreement

Monopar's Breakthrough in Wilson Disease: A New Dawn with AstraZeneca's Shadow

India Greenlights AstraZeneca's Revolutionary Cancer Drug, Offering New Hope to Patients

AstraZeneca's Revolutionary Lung Cancer Drug Receives Green Light in India

A New Horizon in Breast Cancer Treatment: AstraZeneca's Datroway Extends Lives and Boosts Hopes

A New Horizon for Breast Cancer: Enhertu Shows Groundbreaking Survival Benefit in HER2-low Metastatic Patients

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape

AstraZeneca's American Dream: Why a US Listing Could Unlock a 20% Value Surge

AstraZeneca's Bold Leap: Transforming Patient Access with New Direct-to-Consumer Platform

AstraZeneca Unleashes Legal Barrage Against Medicare Drug Price Controls

European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases

Urgent Warning: NHS Must Reignite Medical Innovation to Secure UK's Future in Life Sciences

A New Horizon in Lung Cancer Treatment: Tagrisso Combo Extends Life-Changing Hope

AstraZeneca's Baxdrostat: A Beacon of Hope in the Fight Against Uncontrolled High Blood Pressure

AstraZeneca Unveils Baxdrostat: The 'Miracle Drug' Poised to Revolutionize High Blood Pressure Treatment

A Game-Changer in Hypertension: Baxdrostat Offers New Hope for Resistant High Blood Pressure

A New Horizon in Hypertension Treatment: Baxdrostat Shows Promising Results for Resistant Cases

A New Dawn for Blood Pressure Control: Unveiling Baxdrostat's Revolutionary Potential